| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $45.2B | $39.0B | $33.7B | $31.6B | $29.7B | $6.6B | $5.5B | $4.2B |
| Cost of Revenue | $23.3B | $21.0B | $19.7B | $19.2B | $17.3B | $15.3B | $12.4B | $10.0B |
| Gross Profit | — | — | — | — | — | $2.5B | $2.0B | $1.5B |
| R&D Expense | $3.4B | $2.9B | $2.7B | $2.7B | — | $2.0B | $1.7B | $1.2B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $13.3B | $10.4B | $7.0B | $5.6B | $6.2B | $4.6B | $2.6B | $1.6B |
| Net Income | $11.0B | $8.7B | $5.4B | $4.5B | $5.1B | $0.5B | $0.6B | $0.1B |
| EPS (Basic) | $2.58 | $20.28 | $12.25 | $10.10 | $11.55 | $1.23 | $1.34 | $0.31 |
| EPS (Diluted) | $2.53 | $19.83 | $12.03 | $9.95 | $11.24 | $1.19 | $1.30 | $0.30 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $55.6B | $53.6B | $48.7B | $48.6B | $44.6B | $39.3B | $34.0B | $26.0B |
| Current Assets | $13.0B | $13.1B | $9.9B | $9.3B | $8.1B | $9.8B | $6.2B | $9.7B |
| Cash & Equivalents | $9.0B | $7.8B | $7.1B | $5.1B | $6.0B | $8.2B | $5.0B | $3.8B |
| Total Liabilities | $29.0B | $28.9B | $28.1B | $27.8B | $28.7B | $28.2B | $26.4B | $20.7B |
| Current Liabilities | $11.0B | $10.8B | $8.9B | $7.9B | $8.5B | $7.8B | $6.9B | $6.5B |
| Stockholders' Equity | $26.6B | $24.7B | $20.6B | $20.8B | $15.8B | $11.1B | $7.6B | $5.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $10.1B | $7.4B | $7.3B | $2.0B | $0.4B | $2.4B | $-2.9B | $-2.7B |
| Investing Cash Flow | $1.0B | $-2.2B | $0.5B | $-2.1B | $-1.3B | $-0.5B | $-0.4B | $-0.3B |
| Capital Expenditures | $0.7B | $0.4B | $0.3B | $0.4B | $0.5B | $0.5B | $0.3B | $0.2B |
| Financing Cash Flow | $-10.3B | $-4.1B | $-6.0B | $-0.7B | $-1.1B | $1.2B | $4.5B | $4.0B |